HOME >> BIOLOGY >> NEWS
Anti-fungal drug kills TB bug

Scientists hoping to find new treatments for one of the worlds most deadly infectious diseases say drugs used to treat common fungal infections may provide the answer.

Tuberculosis, or TB, is a highly contagious disease of the lungs that was thought to have been virtually eliminated by the 1960s, but is now resurgent and kills nearly two million people worldwide every year. New infections are occurring at a rate of one per second.

Of equal concern is the dramatic rise in the incidence of new strains of TB that are resistant to traditional antibiotics. As a result, the World Health Organisation, the Bill Gates Foundation and the European Union have all launched initiatives to tackle the problem.

Now, biologists at The University of Manchester have shown that chemicals called azoles the active agent in many antifungal drugs kill the TB bacteria, and could be effective in tackling the emerging drug-resistant strains.

"TB is back with a vengeance with a third of the worlds population currently infected," said Professor Andrew Munro, who led the research in Manchesters Faculty of Life Sciences.

"The bacterium survives the initial attack by the bodys immune system and then lies dormant, usually in the lungs, waiting for any sign of weakness, such as a secondary infection. Its resurgence over the last 20 years has been closely associated with the AIDS epidemic, which destroys the human immune system and has allowed TB to get a grip once again."

London is the TB capital of Europe, although most large cities here and in North America have seen rapid increases in the number of TB infections. However, the problem is most acute in Africa and Asia where HIV/AIDS is also most prolific and a shortage of traditional TB medicines and problems with patient compliance has led to the emergence of drug-resistant strains of the disease.

"There were only ever a limited number of drugs that were effective against TB
'"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
12-Mar-2007


Page: 1 2 3

Related biology news :

1. Anti-fungal drug may help treat cancer
2. Fat kills cancer
3. DNA analysis suggests under-reported kills of threatened whales
4. Ebola-outbreak kills 5000 gorillas
5. HIV-1 kills immune cells in the gut that may never bounce back
6. Scientists design a PSA-activated protoxin that kills prostate cancer
7. The LouseBuster kills
8. Experimental RNA-based drug kills prostate cancer cells effectively and safely
9. Newly discovered protein kills anthrax bacteria by exploding their cell walls
10. No place like home: Ant navigation skills used in robot navigation
11. New research shows bats have complex skills to deal with clutter

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2018)... ... August 21, 2018 , ... Whether it be online or ... to offering customers a successful experience. When browsing the new site in ... products, with relevant details such as technical manuals, application notes, and instrument compatibility ...
(Date:8/17/2018)... ... 16, 2018 , ... With increasing safety requirements, and time and financial pressure, ... multiple challenges. To be successful in such a competitive environment, it is more important ... multiple tasks needed to develop a new drug or to execute fundamental research. ...
(Date:8/17/2018)... (PRWEB) , ... August 16, 2018 , ... ... the world’s first private cord blood bank to separate and store stem cells ... Law Center, and Brian Sheehy, M.D. M.A. C.F.A., Founder and Managing Partner IsZo ...
Breaking Biology News(10 mins):
(Date:9/1/2018)... ... August 31, 2018 , ... Rudina Thanasi, a ... a proprietary biofield energy treated nutraceutical supplement used in combating inflammation and autoimmune ... and blood, as well as, organ-specific inflammation. The reported data is as follows: ...
(Date:8/29/2018)... ... 2018 , ... Nanovis , an innovative and fast-growing ... a $5.5 million funding round managed by Commenda Securities. Key investors include Elevate ... Ventures. , “Our investment in Nanovis is consistent with our mission to support ...
(Date:8/29/2018)... ... August 28, 2018 , ... ... results of a safety study performed on an allogeneic (donor derived) stem cell ... Medicine Association (NAVRMA) conference in September. He is also the organizer of ...
(Date:8/26/2018)... ... August 23, 2018 , ... LabRoots , the ... around the world, will host the 4th Annual Microbiology and Immunology Virtual Event ... disciplines, encompassing various research areas including medicine, agriculture, and space. , During ...
Breaking Biology Technology:
Cached News: